Picture of Hisamitsu Pharmaceutical Co logo

4530 — Hisamitsu Pharmaceutical Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Table: Hisamitsu - 9-MTH group results

Jan 12 (Reuters)-  
             Hisamitsu Pharmaceutical Co Inc  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Nov 30, 2017        Nov 30, 2016     Feb 28, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              109.55              109.73           147.00     
                   (-0.2 pct)          (-10.3 pct)      (+0.7 pct)   
  Operating           20.69               22.00            24.10     
                   (-5.9 pct)          (-5.7 pct)       (-8.4 pct)   
  Recurring           22.04               22.89            25.60     
                   (-3.7 pct)          (-2.5 pct)       (-9.2 pct)   
  Net                 15.84               18.34            18.50     
                   (-13.6 pct)         (+19.7 pct)      (-9.3 pct)   
  EPS              189.33 yen          216.23 yen       221.12 yen   
  EPS Diluted      189.19 yen          216.12 yen                    
  Ann Div                               81.50 yen        82.00 yen   
  -Q2 div           41.00 yen           40.50 yen                    
  -Q4 div                               41.00 yen        41.00 yen   
   
  NOTE - Hisamitsu Pharmaceutical Co Inc.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Hisamitsu Pharmaceutical Co

See all news